Persistency of adenoviral-mediated lysostaphin expression in goat mammary glands

Journal of Dairy Science

Volumn 87, Issue 3, 2004, Pages 602-608

  Fan, W ^a   Plaut, K ^a   Bramley, A J ^a   Barlow, J W ^a   Mischler, S A ^a   Kerr, D E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Adenovirus; Antibody; Lysostaphin; Mastitis

Indexed keywords

ADENOVIRIDAE; ANIMALIA; CAPRA HIRCUS;

IMMUNOGLOBULIN G; LYSOSTAPHIN ENDOPEPTIDASE; PROTEINASE; RECOMBINANT DNA; VIRUS ANTIBODY;

ADENOVIRUS; ANIMAL; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; GOAT; IMMUNOLOGY; SECRETION; UDDER;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; DNA, RECOMBINANT; ENDOPEPTIDASES; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GOATS; IMMUNOGLOBULIN G; MAMMARY GLANDS, ANIMAL; TRANSFECTION;

EID: 3142660538     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(04)73202-6     Document Type: Article

References (29)

1. Adam, M., W. Oualikene, H. Le Cocq, M. Guittet, and M. Eloit. 1995. Replication-defective adenovirus type 5 as an in vitro and in vivo gene transfer vector in chickens. J. Gen. Virol. 76:3153-3157.
2. Archer, J. S., W. S. Kennan, M. N. Gould, and R. D. Bremel. 1994. Human growth hormone (hGH) secretion in milk of goats after direct transfer of the hGH gene into the mammary gland by using replication- defective retrovirus vectors. Proc. Natl. Acad. Sci. USA 91:6840-6844.
3. Bramley, A. J., and R. Foster. 1990. Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland. Res. Vet. Sci. 49:120-121.
4. Chen, L. M., L. Chao, and J. Chao. 1997. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. Hum. Gene Ther. 8:341-347.
5. Clemens, P. R., S. Kochanek, Y. Sunada, S. Chan, H. H. Chen, K. P. Campbell, and C. T. Caskey. 1996. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3:965-972.
6. Connelly, S., J. M. Gardner, A. McClelland, and M. Kaleko. 1996. High-level tissue-specific expression of functional human factor VIII in mice. Hum. Gene Ther. 7:183-195.
7. Connelly, S., T. A. G. Smith, G. Dhir, J. M. Gardner, M. G. Mehaffey, K. S. Zaret, A. McClelland, and M. Kaleko. 1995. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6:185-193.
8. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
9. Daley, M. J., and E. R. Oldham. 1992. Lysostaphin: Immunogenicity of locally administered recombinant protein used in mastitis therapy. Vet. Immunol. Immunopathol. 31:301-312.
10. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617-648.
11. Engelhardt, J. F., R. H. Simon, Y. Yang, M. Zepeda, S. Weber-Pendleton, B. Doranz, M. Grossman, and J. M. Wilson. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:759-769.
12. Fan, W., K. Plaut, A. J. Bramley, J. W. Barlow, and D. E. Kerr. 2002. Adenoviral-mediated transfer of a lysostaphin gene into the goat mammary gland. J. Dairy Sci. 85:1709-1716.
13. Gogev, S., N. Vanderheijden, M. Lemaire, F. Schynts, J. D'Offay, I. Deprez, M. Adam, M. Eloit, and E. Thiry. 2002. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine 20:1451-1465.
14. Gonin, P., A. Fournier, W. Oualikene, A. Moraillon, and M. Eloit. 1995. Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus. Vet. Microbiol. 45:393-401.
15. Harmon, R. J., F. L. Schanbacher, L. C. Ferguson, and K. L. Smith. 1976. Changes in lactoferrin, immunoglobulin G, bovine serum albumin, and alpha-lactalbumin during acute experimental and natural coliform mastitis in cows. Infect. Immun. 13:533-542.
16. Kerr, D. E., K. Plaut, A. J. Bramley, C. M. Williamson, A. J. Lax, K. Moore, K. D. Wells, and R. J. Wall. 2001. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat. Biotechnol. 19:66-70.
17. Kim, I. H., A. Jozkowicz, P. A. Piedra, K. Oka, and L. Chan. 2001. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. USA 98:13282-13287.
18. Lozier, J. N., M. E. Metzger, R. E. Donahue, and R. A. Morgan. 1999. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity. Blood 94:3968-3975.
19. Mittal, S. K., Z. Papp, S. K. Tikoo, M. E. Baca-Estrada, D. Yoo, M. Benko, and L. A. Babiuk. 1996. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222:299-309.
20. Morsy, M. A., M. Gu, S. Motzel, J. Zhao, J. Lin, Q. Su, H. Allen, L. Franlin, R. J. Parks, F. L. Graham, S. Kochanek, A. J. Bett, and C. T. Caskey. 1998. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. USA 95:7866-7871.
21. Nordhaug, M. L., L. L. Nesse, N. L. Norcross, and R. Gudding. 1994. A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 2. Antibody response. J. Dairy Sci. 77:1276-1284.
22. Oldham, E. R., and M. J. Daley. 1991. Lysostaphin: Use of a recombinant bactericidal enzyme as a mastitis therapeutic. J. Dairy. Sci. 74:4175-4182.
23. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, and L. Stratford-Perricaudet. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
24. Smith, T. A. G., M. G. Mehaffey, D. B. Kayda, J. M. Saunders, S. Yei, B. C. Trapnell, A. McClelland, and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5:397-402.
25. Sullivan, D. E., S. Dash, H. Du, N. Hiramatsu, F. Aydin, J. Kolls, J. Blanchard, G. Baskin, and M. A. Gerber. 1997. Liver-directed gene transfer in non-human primates. Hum. Gene Ther. 8:1195-1206.
26. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, and A. Friedman. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
27. Xiang, Z. Q., Y. Yang, J. M. Wilson, and H. C. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220-227.
28. Yang, Y., K. U. Jooss, Q. Su, H. C. Ertl, and J. M. Wilson. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
29. Ye, X., M. B. Robinson, M. L. Batshaw, E. E. Furth, I. Smith, and J. M. Wilson. 1996. Prolonged metabolic correction in adult ornithine transcarbamylase- deficient mice with adenoviral vectors. J. Biol. Chem. 271:3639-3646.